pepmg_

Study summary · research use only

Acetyl-L-carnitine attenuates Poly I:C-induced sickness behavior in mice

Study · animal · Bioscience, biotechnology, and biochemistry · 2022 · DOI 10.1093/bbb/zbac132 · PMID 35945649

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

In this male mouse study (C3H/HeN strain), researchers examined whether acetyl-L-carnitine (ALC), given for 5 days before Poly I:C administration, altered Poly I:C-induced sickness behavior. The abstract reports ALC administration was associated with an attenuated decrease in wheel behavior activity at 24 h after Poly I:C administration, and that ALC-treated mice recovered from sickness behavior more quickly. Brain-derived neurotrophic factor (BDNF) gene expression in the cerebrum and hippocampus was higher in the ALC-treated group, and translocator protein 18kDa (TSPO) was upregulated in the cerebrum and hippocampus, findings the authors associate with cytoprotective effects related to the attenuated activity decrease after Poly I:C treatment.

Abstract

Fatigue is accompanied by a decrease in physical activity or malaise, and might be reduced by acetyl-L-carnitine (ALC) administration. The purpose of this study was to investigate the preventive effects of ALC on Poly I:C-induced sickness behavior in mice. For the experiment, male C3H/HeN mice were used and treated with ALC for 5 days before Poly I:C administration. ALC administration attenuated the decrease in wheel behavior activity of mice at 24 h after Poly I:C administration and ALC-treated mice quickly recovered from the sickness behavior. The gene expression of brain-derived neurotrophic factor (BDNF) in the cerebrum and hippocampus, which is associated with physical activity, was higher in the ALC-treated group. Translocator protein 18kDa (TSPO), which has cytoprotective effects, was up-regulated in the cerebrum and hippocampus, suggesting that ALC suppressed the decrease in activity induced by Poly I:C treatment through enhancement of cytoprotective effects in the brain.

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.